Phase I/II study of biweekly nab-paclitaxel in patients with platinum-pretreated non-small cell lung cancer: NJLCG1402.

Miyauchi E, Tanaka H, Nakamura A, Harada T, Nakagawa T, Morita M, Jingu D, Kuda T, Gamou S, Saito R, Inoue A

Open source

DOI
10.1111/1759-7714.14149
Published
2021 Nov
Container
Thoracic cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/1759-7714.14149,
  title = {Phase I/II study of biweekly nab-paclitaxel in patients with platinum-pretreated non-small cell lung cancer: NJLCG1402.},
  author = {Miyauchi E and Tanaka H and Nakamura A and Harada T and Nakagawa T and Morita M and Jingu D and Kuda T and Gamou S and Saito R and Inoue A},
  year = {2021},
  journal = {Thoracic cancer},
  doi = {10.1111/1759-7714.14149},
  url = {https://doi.org/10.1111/1759-7714.14149}
}

RIS

TY  - JOUR
TI  - Phase I/II study of biweekly nab-paclitaxel in patients with platinum-pretreated non-small cell lung cancer: NJLCG1402.
AU  - Miyauchi E
AU  - Tanaka H
AU  - Nakamura A
AU  - Harada T
AU  - Nakagawa T
AU  - Morita M
AU  - Jingu D
AU  - Kuda T
AU  - Gamou S
AU  - Saito R
AU  - Inoue A
PY  - 2021
JO  - Thoracic cancer
DO  - 10.1111/1759-7714.14149
UR  - https://doi.org/10.1111/1759-7714.14149
ER  - 

APA

E, M., H, T., A, N., T, H., T, N., M, M., D, J., T, K., S, G., R, S., & A, I. (2021). Phase I/II study of biweekly nab-paclitaxel in patients with platinum-pretreated non-small cell lung cancer: NJLCG1402.. Thoracic cancer. https://doi.org/10.1111/1759-7714.14149

Source records